CA2028048C - Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol - Google Patents

Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol Download PDF

Info

Publication number
CA2028048C
CA2028048C CA002028048A CA2028048A CA2028048C CA 2028048 C CA2028048 C CA 2028048C CA 002028048 A CA002028048 A CA 002028048A CA 2028048 A CA2028048 A CA 2028048A CA 2028048 C CA2028048 C CA 2028048C
Authority
CA
Canada
Prior art keywords
mannitol
imino
dideoxy
give
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002028048A
Other languages
English (en)
French (fr)
Other versions
CA2028048A1 (en
Inventor
George W. J. Fleet
Neil M. Carpenter
Bryan G. Winchester
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/424,628 external-priority patent/US5023340A/en
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of CA2028048A1 publication Critical patent/CA2028048A1/en
Application granted granted Critical
Publication of CA2028048C publication Critical patent/CA2028048C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002028048A 1989-10-20 1990-10-19 Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol Expired - Fee Related CA2028048C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US424,628 1989-10-20
US07/424,628 US5023340A (en) 1989-10-20 1989-10-20 Pyrrolizioines and synthesis thereof
US461,859 1990-01-08
US07/461,859 US4996329A (en) 1989-10-20 1990-01-08 Derivatives of 1,4-dideoxy-1,4-imino-D-mannitol and a process for their preparation

Publications (2)

Publication Number Publication Date
CA2028048A1 CA2028048A1 (en) 1991-04-21
CA2028048C true CA2028048C (en) 2001-06-19

Family

ID=27026400

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002028048A Expired - Fee Related CA2028048C (en) 1989-10-20 1990-10-19 Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol

Country Status (9)

Country Link
US (1) US4996329A (es)
EP (1) EP0424350B1 (es)
JP (1) JP2975665B2 (es)
AT (1) ATE117992T1 (es)
CA (1) CA2028048C (es)
DE (1) DE69016571T2 (es)
DK (1) DK0424350T3 (es)
ES (1) ES2069060T3 (es)
GR (1) GR3015238T3 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100797A (en) * 1989-06-27 1992-03-31 Monsanto Company Fucosidase inhibitors
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
CA2267412A1 (en) * 1996-10-01 1998-04-09 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
US5952363A (en) * 1997-03-04 1999-09-14 Novo Nordisk A/S Pyrrolidine compounds useful in the treatment of diabetes
JP2001514632A (ja) * 1997-03-07 2001-09-11 ノボ ノルディスク アクティーゼルスカブ 新規ヘテロサイクリック化合物
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
CA2307595A1 (en) * 1997-10-24 1999-05-06 Glycodesign Inc. Synthesis of swainsonine salts
US7256005B2 (en) 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
EP1210082B1 (en) * 1999-08-10 2008-01-02 The Chancellor, Masters And Scholars Of The University Of Oxford Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions
WO2008088581A2 (en) * 2006-08-02 2008-07-24 United Therapeutics Corporation Liposome treatment of viral infections
WO2008063727A2 (en) * 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
WO2009118658A2 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
JP2012521981A (ja) * 2009-03-27 2012-09-20 ザ チャンセラー，マスターズ アンド スカラーズ オブ ザ ユニバーシティ オブ オックスフォード コレステロールレベル低下リポソーム

Also Published As

Publication number Publication date
ATE117992T1 (de) 1995-02-15
GR3015238T3 (en) 1995-06-30
DE69016571D1 (de) 1995-03-16
DK0424350T3 (da) 1995-04-10
JPH03151359A (ja) 1991-06-27
CA2028048A1 (en) 1991-04-21
EP0424350A1 (en) 1991-04-24
DE69016571T2 (de) 1995-09-07
EP0424350B1 (en) 1995-02-01
JP2975665B2 (ja) 1999-11-10
ES2069060T3 (es) 1995-05-01
US4996329A (en) 1991-02-26

Similar Documents

Publication Publication Date Title
CA2028048C (en) Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol
Gerspacher et al. 2-Amino-2-deoxyhexoses as chiral educts for hydroxylated indolizidines. Synthesis of (+)-castanospermine and (+)-6-epicastanospermine
MX2007002419A (es) Sintesis alternativa de inhibidores de renina e intermediarios de los mismos.
US5200523A (en) Synthesis of nojirimycin derivatives
CA2034643A1 (en) Synthesis of chiral pyrrolidine and piperidine glycosidase inhibitors
CA2329660A1 (en) Inhibitors of neuraminidases
US5041555A (en) Derivatives of 1,4-dideoxy-1,4-imino-D-mannitol and preparation thereof
US5100797A (en) Fucosidase inhibitors
Myerscough et al. Inhibition of α-mannosidases by seven carbon sugars: synthesis of some seven carbon analogues of mannofuranose
EP0443498A1 (en) Isoindoline derivatives
US5023340A (en) Pyrrolizioines and synthesis thereof
CA2019799A1 (en) Fucosidase inhibitor
Long et al. Open-chain acetonides of D-galactono-1, 4-lactone as starting materials for pyrrolidines, azepanes and 5-azidomethyltetrahydrofuran-2-carboxylates: monomers for polyhydroxylated nylon and for tetrahydrofuran carbopeptoids
US5075448A (en) Synthesis of swainsonine and analogs thereof
US5286877A (en) Synthesis of 1,4-dideoxy-1,4-imino-L-arabinitol
US7511154B2 (en) Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts
US5075457A (en) Synthesis of swainsonine and analogs thereof
US3312716A (en) 4-hydroxy-3-pyrrolidinemethanols
IKOTA Stereoselective Synthesis of (+)-1, 8-Di-epi-and (-)-1-epi-Swainsonine from an (S)-Pyroglutamic Acid Derivative
US5384417A (en) Heptitols
CA1124726A (en) Derivatives of pyrrolidinecarboxaldehyde and piperidinecarboxaldehyde and intermediates therefor
WO1994015617A1 (en) 8a-aza and 9a-aza macrolide antibiotics, and a process for producing same and methods of use
US5248779A (en) Synthesis of nojirimycin derivatives
US5153325A (en) Fucosidase inhibitor
WO1993023361A1 (en) Process for the preparation of a substituted diaminodiol

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20071019